NCT07252557

Brief Summary

This single-center randomized controlled trial evaluates the effects of cold (15-20°C) versus room-temperature (30-35°C) water gargling on oral mucositis severity, pain, and comfort in patients with head and neck cancer undergoing radiotherapy. Participants will rinse their mouth four times daily for 30-60 seconds over a 6-week radiotherapy course, with follow-up for two additional weeks. The study hypothesizes that cold-water rinsing can reduce the severity of radiation-induced oral mucositis (RTOM) and pain, improve oral comfort, and minimize treatment interruptions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Jan 2026Mar 2027

First Submitted

Initial submission to the registry

November 18, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 26, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

November 26, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

November 18, 2025

Last Update Submit

November 24, 2025

Conditions

Keywords

Head and Neck CancerRadiation-Induced Oral MucositisWater TemperatureCold Water RinseSupportive CarePain ManagementRadiotherapyNursing Intervention

Outcome Measures

Primary Outcomes (2)

  • Oral Mucositis Severity

    Assessed using WHO Oral Mucositis Grading Scale (0-4).

    Baseline (prior to radiotherapy), Week 2, Week 4, Week 6 (end of radiotherapy), and 2 weeks after completion of radiotherapy

  • Pain Intensity (VAS 0-10)

    Patient-reported pain intensity using VAS (0-10).

    Baseline (prior to radiotherapy), Weeks 1-6 during radiotherapy, and 2 weeks after completion of radiotherapy

Secondary Outcomes (3)

  • Oral Comfort

    Baseline, Week 2, Week 4, Week 6 (end of radiotherapy)

  • Satisfaction with Rinsing Modality

    Week 6 (end of radiotherapy) and 2 weeks after completion of radiotherapy

  • Psychological Distress

    Baseline (prior to radiotherapy) and Week 6 (end of radiotherapy)

Study Arms (2)

Cold Water Rinse

EXPERIMENTAL

Participants will rinse their mouth with cold water at approximately 15-20°C, four times daily for 30-60 seconds throughout six weeks of radiotherapy, followed by a two-week follow-up period.

Behavioral: Water Rinse at Different Temperatures

Room Temperature Water Rinse

NO INTERVENTION

Participants will rinse their mouth with room-temperature water at approximately 30-35°C, with identical frequency and duration as the experimental arm.

Interventions

rinse their mouth with cold water at approximately 15-20°C

Cold Water Rinse

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically confirmed head and neck cancer (HNC) receiving radiotherapy for the first time, with or without concurrent chemotherapy.
  • Conscious, communicative, and able to perform the rinsing procedure and complete questionnaires.
  • Provided written informed consent prior to enrollment.

You may not qualify if:

  • Non-HNC diagnoses or radiotherapy to sites outside the oral/oropharyngeal region.
  • Cognitive impairment or inability to complete the rinsing protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chung Shan Medical University

Taichung, Taiwan (r.o.c.), Taiwan

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsAgnosia

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Yueh-Chun Lee, MD-PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2025

First Posted

November 26, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

March 31, 2027

Last Updated

November 26, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations